Teva Pharmaceuticals to Pay $54 Million to Settle Healthcare-Based FCA Claims
A qui tam False Claims Act action brought by two whistleblowers alleging violations of the Anti-Kickback Statute has resulted in a $54-million settlement from Teva Pharmaceuticals USA, Inc.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.